Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer.

Autor: Willeumier JJ; Leiden University Medical Center, Leiden, The Netherlands., van der Hoeven NM; Leiden University Medical Center, Leiden, The Netherlands., Bollen L; Leiden University Medical Center, Leiden, The Netherlands., Willems LN; Leiden University Medical Center, Leiden, The Netherlands., Fiocco M; Leiden University Medical Center, Leiden, The Netherlands., van der Linden YM; Leiden University Medical Center, Leiden, The Netherlands., Dijkstra PD; Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: The bone & joint journal [Bone Joint J] 2017 Apr; Vol. 99-B (4), pp. 516-521.